Global Anesthetic Drugs Market (2021 to 2026) – by Drug Type, Route of Administration, Application and Geography – PRNewswire

Searching for your content…
In-Language News
Contact Us
888-776-0942
from 8 AM – 10 PM ET
News provided by
Feb 18, 2022, 10:30 ET
Share this article
DUBLIN, Feb. 18, 2022 /PRNewswire/ — The "Global Anesthetic Drugs Market (2021-2026) by Drug Type, Route of Administration, Application, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com’s offering.
The Global Anesthetic Drugs Market is estimated to be USD 4.68 Bn in 2021 and is expected to reach USD 6.42 Bn by 2026, growing at a CAGR of 6.52%.

Market Dynamics
The major factors driving the growth of the global anesthetic drugs market are the growing number of operations such as cardiac, orthopedic, general surgeries, and pain management. Furthermore, technological advancements in drug delivery devices, the development of specific targeted drugs, and patient monitoring devices for monitoring physiological parameters of patients during and after anesthesia and reduced anesthetic drug side effects are all expected to drive market growth over the forecast period. In addition, the decreasing cost of newly created medications and the decrease in the recovery period after surgery is creating more opportunities for the market.

However, some side-effects caused by anesthetic drugs, including nausea, vomiting, disorientation, sore throat, muscle aches, etc., and stringent policy and regulations imposed by the government are restraining and creating challenges for the market growth.
The Global Anesthetic Drugs Market is segmented based on Drug Type, Route of Administration, Application, and Geography.

Company Profiles
Some of the companies covered in this report are Abbott Laboratories, AbbVie Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, etc.

Countries Studied
Competitive Quadrant
The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?
Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Influencers
4.1 Drivers
4.1.1 Increase in Surgical Procedures
4.1.2 Substantial Demand for Post-Operative Pain Relief Options
4.1.3 The Rise in Pain Management
4.2 Restraints
4.2.1 Side Effects of Some Anesthetic Drugs
4.3 Opportunities
4.3.1 Innovations in Drug Delivery Technologies
4.3.2 Growing Healthcare Sectors in Developing Countries
4.4 Challenges
4.4.1 Lack of Skilled-Anesthetics

5 Market Analysis
5.1 Porter’s Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis

6 Global Anesthetic Drugs Market, By Type
6.1 Introduction
6.2 General Anesthesia Drugs
6.2.1 Propofol
6.2.2 Sevoflurane
6.2.3 Desflurane
6.2.4 Dexmedetomidine
6.2.5 Remifentanil
6.2.6 Midazolam
6.2.7 Other
6.3 Local Anesthesia Drugs
6.3.1 Bupivacaine
6.3.2 Ropivacaine
6.3.3 Lidocaine
6.3.4 Chloroprocaine
6.3.5 Prilocaine
6.3.6 Benzocaine
6.3.7 Other

7 Global Anesthetic Drugs Market, By Route of Administration
7.1 Introduction
7.2 Inhalation
7.3 Injection
7.4 Topical

8 Global Anesthetic Drugs Market, By Application
8.1 Introduction
8.2 General Surgery
8.3 Plastic Surgery
8.4 Cosmetic Surgery
8.5 Dental Surgery
8.6 Other

9 Global Anesthetic Drugs Market, By Geography

10 Competitive Landscape
10.1 Competitive Quadrant
10.2 Market Share Analysis
10.3 Strategic Initiatives
10.3.1 M&A and Investments
10.3.2 Partnerships and Collaborations
10.3.3 Product Developments and Improvements

11 Company Profiles
11.1 Abbott Laboratories
11.2 AbbVie Inc
11.3 Aspen Pharmacare Holdings Limited
11.4 AstraZeneca plc
11.5 B. Braun Melsungen AG
11.6 Baxter International Inc
11.7 Claris Lifesciences Limited
11.8 Dr. Reddy’s Laboratories
11.9 Eisai Co. Ltd
11.10 F. Hoffmann-La Roche Ltd
11.11 Fresenius SE & Co. KGaA
11.12 Glenmark Pharmaceuticals Limited
11.13 Hikma Pharmaceuticals PLC
11.14 Hospira, Inc
11.15 Maruishi Pharmaceutical Co., Ltd
11.16 Nuventra Pharma Sciences
11.17 Pacira Pharmaceuticals, Inc
11.18 Paion UK Ltd
11.19 Pfizer Inc
11.20 Piramal Enterprises LTD
11.21 Septodont Healthcare India Pvt. Ltd
11.22 Slayback Pharma LLC
11.23 Teva Pharmaceutical Industries Limited
11.24 Troikaa Pharmaceuticals Ltd.
11.25 Viatris Inc

12 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/wcdcx2
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
More news releases in similar topics
Cision Distribution 888-776-0942
from 8 AM – 9 PM ET

source